White & Case advised Karo Pharma on the deal. Roschier advised the sellers in the transaction. Karo Pharma executed the acquisition of Sylphar for €300 million...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here